首页 | 本学科首页   官方微博 | 高级检索  
     


A CGRP receptor antagonist peptide formulated for nasal administration to treat migraine
Authors:Bengt von Mentzer  Andrew F. Russo  Zhongming Zhang  Adisa Kuburas  Patrick M. Killoran  Vera D’Aloisio  Laura Nizic  Vicky Capel  David A. Kendall  Christopher R. Coxon  Gillian A. Hutcheon
Affiliation:1. Innovipharm Limited, West Kirby, UK;2. Department of Molecular Physiology and Biophysics, Center for Prevention and Treatment of Visual Loss, Veterans Administration Health Center, University of Iowa, Iowa City, IA, USA;3. College of Medicine, Henan Key Laboratory of Zhang Zhongjing Formulae and Herbs for Immunoregulation, Nanyang Institute of Technology, Nanyang, Henan, China;4. Division of Structural Biology (STRUBI), Harwell Campus, University of Oxford, Didcot, UK;5. School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK;6. Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia;7. Catalent Pharma Solutions, Nottingham, UK;8. Innovipharm Limited, West Kirby, UK

School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK;9. Institute of Chemical Sciences, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh, UK

Abstract:
Keywords:aCGRP (8-37)  aCGRP (27-37)  cAMP  plasma extravasation  SK-N-MC
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号